<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(7)</volume><submitter>Richard D</submitter><pubmed_abstract>The angiotensin-converting enzyme 2 (ACE2) protein is a key catalytic regulator of the renin-angiotensin system (RAS), involved in fluid homeostasis and blood pressure modulation. ACE2 also serves as a cell-surface receptor for some coronaviruses such as &lt;i>SARS-CoV&lt;/i> and &lt;i>SARS-CoV-2&lt;/i>. Improved characterization of &lt;i>ACE2&lt;/i> regulation may help us understand the effects of pre-existing conditions on COVID-19 incidence, as well as pathogenic dysregulation following viral infection. Here, we perform bioinformatic analyses to hypothesize on &lt;i>ACE2&lt;/i> gene regulation in two different physiological contexts, identifying putative regulatory elements of &lt;i>ACE2&lt;/i> expression. We perform functional validation of our computational predictions via targeted CRISPR-Cas9 deletions of these elements &lt;i>in vitro&lt;/i>, finding them responsive to immune signaling and oxidative-stress pathways. This contributes to our understanding of &lt;i>ACE2&lt;/i> gene regulation at baseline and immune challenge. Our work supports pursuit of these putative mechanisms in our understanding of infection/disease caused by current, and future, SARS-related viruses such as &lt;i>SARS-CoV-2&lt;/i>.</pubmed_abstract><journal>iScience</journal><pagination>104614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9213013</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways.</pubmed_title><pmcid>PMC9213013</pmcid><pubmed_authors>Hirota J</pubmed_authors><pubmed_authors>Muthuirulan P</pubmed_authors><pubmed_authors>Mossman K</pubmed_authors><pubmed_authors>Capellini TD</pubmed_authors><pubmed_authors>Doxey AC</pubmed_authors><pubmed_authors>Banerjee A</pubmed_authors><pubmed_authors>Richard D</pubmed_authors><pubmed_authors>Aguiar J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways.</name><description>The angiotensin-converting enzyme 2 (ACE2) protein is a key catalytic regulator of the renin-angiotensin system (RAS), involved in fluid homeostasis and blood pressure modulation. ACE2 also serves as a cell-surface receptor for some coronaviruses such as &lt;i>SARS-CoV&lt;/i> and &lt;i>SARS-CoV-2&lt;/i>. Improved characterization of &lt;i>ACE2&lt;/i> regulation may help us understand the effects of pre-existing conditions on COVID-19 incidence, as well as pathogenic dysregulation following viral infection. Here, we perform bioinformatic analyses to hypothesize on &lt;i>ACE2&lt;/i> gene regulation in two different physiological contexts, identifying putative regulatory elements of &lt;i>ACE2&lt;/i> expression. We perform functional validation of our computational predictions via targeted CRISPR-Cas9 deletions of these elements &lt;i>in vitro&lt;/i>, finding them responsive to immune signaling and oxidative-stress pathways. This contributes to our understanding of &lt;i>ACE2&lt;/i> gene regulation at baseline and immune challenge. Our work supports pursuit of these putative mechanisms in our understanding of infection/disease caused by current, and future, SARS-related viruses such as &lt;i>SARS-CoV-2&lt;/i>.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2024-10-18T18:38:20.349Z</modification><creation>2022-07-10T02:22:24.829Z</creation></dates><accession>S-EPMC9213013</accession><cross_references><pubmed>35756893</pubmed><doi>10.1016/j.isci.2022.104614</doi></cross_references></HashMap>